Fadi N Salloum, Carlo G Tocchetti, Pietro Ameri, Hossein Ardehali, Aarti Asnani, Rudolf A de Boer, Paul Burridge, José-Ángel Cabrera, Javier de Castro, Raúl Córdoba, Ambra Costa, Susan Dent, Daniel Engelbertsen, María Fernández-Velasco, Mike Fradley, José J Fuster, Carlos Galán-Arriola, Inés García-Lunar, Alessandra Ghigo, Anna González-Neira, Emilio Hirsch, Borja Ibáñez, Richard N Kitsis, Suma Konety, Alexander R Lyon, Pilar Martin, Adolfo G Mauro, Manuel M Mazo Vega, Wouter C Meijers, Tomas G Neilan, Tienush Rassaf, Melanie Ricke-Hoch, Pilar Sepulveda, Paaladinesh Thavendiranathan, Peter van der Meer, Valentin Fuster, Bonnie Ky, Teresa López-Fernández
Despite improvements in cancer survival, cancer therapy-related cardiovascular toxicity has risen to become a prominent clinical challenge. This has led to the growth of the burgeoning field of cardio-oncology, which aims to advance the cardiovascular health of cancer patients and survivors, through actionable and translatable science. In these Global Cardio-Oncology Symposium 2023 scientific symposium proceedings, we present a focused review on the mechanisms that contribute to common cardiovascular toxicities discussed at this meeting, the ongoing international collaborative efforts to improve patient outcomes, and the bidirectional challenges of translating basic research to clinical care...
December 2023: JACC CardioOncology